27-Hydroxycholesterol Enhances Secretion of Extracellular Vesicles by ROS-Induced Dysregulation of Lysosomes
Authors:
- Anasuya Das GuptaAGAnasuya Das Gupta
- Jaena ParkJPJaena Park
- Janet E SorrellsJSJanet E Sorrells
- Natalia KrawczynskaNKNatalia Krawczynska
- Dhanya PradeepDPDhanya Pradeep
- Hashni Epa Vidana GamageHGHashni Epa Vidana Gamage
- Stephen A BoppartSBStephen A Boppart
- Marni D BoppartMBMarni D Boppart
- Erik R NelsonENErik R Nelson
- 19 September 2024
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 165 (11)
Abstract
Extracellular vesicles (EVs) serve as crucial mediators of cell-to-cell communication in normal physiology as well as in diseased states; they have been largely studied in regard to their role in cancer progression. However, the mechanisms by which their biogenesis and secretion are regulated by metabolic or endocrine factors remain unknown. Here, we delineate a mechanism by which EV secretion is regulated by a cholesterol metabolite, 27-hydroxycholesterol (27HC), where treatment of myeloid immune cells (RAW 264.7 and J774A.1) with 27HC impairs lysosomal homeostasis, leading to shunting of multivesicular bodies (MVBs) away from lysosomal degradation, toward secretion as EVs. This altered lysosomal function is likely caused by mitochondrial dysfunction and subsequent increase in reactive oxygen species (ROS). Interestingly, cotreatment with a mitochondria-targeted antioxidant rescued the lysosomal impairment and attenuated the 27HC-mediated increase in EV secretion. Overall, our findings establish how a cholesterol metabolite regulates EV secretion and paves the way for the development of strategies to regulate cancer progression by controlling EV secretion.Keywords
This publication has 82 references indexed in Scilit:
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Hypoxia promotes EV secretion by impairing lysosomal homeostasis in HNSCC through negative regulation of ATP6V1A by HIF‐1αJournal of Extracellular Vesicles, 2023
- Boosting ROS‐Mediated Lysosomal Membrane Permeabilization for Cancer Ferroptosis TherapyAdvanced Healthcare Materials, 2022
- Targeting the liver X receptor with dendrogenin A differentiates tumour cells to secrete immunogenic exosome‐enriched vesiclesJournal of Extracellular Vesicles, 2022
- Neddylation of Coro1a determines the fate of multivesicular bodies and biogenesis of extracellular vesiclesJournal of Extracellular Vesicles, 2021
- 27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progressionCancer Letters, 2020
- The Contribution of Cholesterol and Its Metabolites to the Pathophysiology of Breast CancerDiscover Oncology, 2016
- Macrophage Infection Models for Mycobacterium tuberculosis2015
- Mitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosisHepatology, 2011
- Functional macrophage cell lines transformed by abelson leukemia virusCell, 1978